Читать книгу Psychogeriatria - Группа авторов - Страница 30

1. Jack C.R. Jr, Albert M.S., Knopman D.S. i wsp. Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7(3): 257–262.

2. Khachaturian Z.S., Petersen R.C., Snyder P.J. i wsp. Developing a global strategy to prevent Alzheimer’s disease: Leon Thal Symposium 2010. Alzheimers Dement. 2011; 7(2): 127–132.

3. Barcikowska M. Choroba Alzheimera. W: Stępień A. (red.). Neurologia. Tom II. Medical Tribune Polska, Warszawa 2014.

4. Knopman D.S., DeKosky S.T., Cummings J.L. i wsp. Practice parameter: diagnosis of dementia (an evidencebased review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56(9): 1143–1153.

5. Weiner M.W., Veitch D.P., Aisen P.S. i wsp. 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2015; 11(6): e1–e120.

6. Dubois B., Hampel H., Feldman H.H. i wsp. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016; 12(3): 292–323.

7. Barcikowska M. Choroba Alzheimera – rozpoznawanie. W: Diagnostyka i leczenie otępień. Rekomendacje zespołu ekspertów Polskiego Towarzystwa Alzheimerowskiego. MediSfera, Warszawa 2012.

8. Hort J., O’Brien J.T., Gainotti G. i wsp. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur. J. Neurol. 2010; 17(10): 1236–1248.

9. Creavin S.T., Wisniewski S., Noel-Storr A.H. i wsp. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst. Rev. 2016; (1): CD011145.

10. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 1982; 139(9): 1136–1139.

11. McKhann G.M., Knopman D.S., Chertkow H. i wsp. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7(3): 263–269.

12. International Statistical Classification of Diseases and Related Health Problems (ICD-10). Volume I. World Health Organization, Geneva 2009.

13. Sorbi S., Hort J., Erkinjuntti T. i wsp. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur. J. Neurol. 2012; 19(9): 1159–1179.

14. Schmidt R., Hofer E., Bouwman F.H. i wsp. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease. Eur. J. Neurol. 2015; 22(6): 889–898.

15. Sobów T., Kłoszewska I. Choroba Alzheimera – leczenie. W: Diagnostyka i leczenie otępień. Rekomendacje zespołu ekspertów Polskiego Towarzystwa Alzheimerowskiego. MediSfera, Warszawa 2012.

16. Sperling R.A., Aisen P.S., Beckett L.A. i wsp. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7(3): 280–292.

17. Scheltens P., Blennow K., Breteler M.M. i wsp. Alzheimer’s disease. Lancet 2016; pii: S0140-6736(15)01124-1.